INTRODUCTION {#S1}
============

The mammalian retina is composed of seven major cell classes, with intrinsic cues being sufficient for specification of the majority of cell types ([@R5]; [@R6]; [@R20]; [@R28]). Retinal photoreceptors comprise two major classes, the rods and cones, which detect dim and bright light, respectively. Several transcription factors have been identified that regulate photoreceptor differentiation. Some, such as the homeodomain factors Otx2 and Crx, are required for the differentiation and survival of both rods and cones ([@R7]; [@R17]; [@R33]). Others, including Rorβ, Nrl and Nr2e3, repress the expression of cone-specific genes in rod photoreceptor precursors while often also activating the expression of rod-specific genes ([@R1]; [@R18]; [@R24]; [@R31]). A number of cone-expressed transcription factors have been identified, including Trβ (Thrβ), Rxrγ and Rorα, which together with the E3 SUMO ligase Pias3 simultaneously drive expression of medium wavelength-sensitive cone opsin (Mop; *Opn1mw*) while repressing the expression of short wavelength-sensitive cone opsin (Sop; *Opn1sw*) ([@R15]; [@R35]; [@R43]; [@R44]).

Photoreceptors synapse onto both bipolar interneurons and GABAergic interneurons known as horizontal cells. Horizontal cells send lateral inhibitory projections to multiple nearby photoreceptors through their large dendritic arbors, enhancing spatial resolution in light detection. Horizontal cells exit mitosis between embryonic day (E) 12 and E16 in mice, and initially migrate towards the ganglion cell layer, but then reverse direction and migrate towards their final position at the outer edge of the inner nuclear layer ([@R14]). Several transcription factors regulate horizontal cell differentiation, including Foxn4, Ptf1a and Prox1 ([@R13]; [@R16]; [@R26]). Prox1 regulates the expression of Lhx1, which is necessary for horizontal cells to adopt their appropriate laminar position. Horizontal cells of *Lhx1^−/−^* mice fail to undergo radial migration and instead adopt positions in the inner portion of the inner nuclear layer, resembling wide-field amacrine cells in their morphology and dendritic arborization, while continuing to express molecular markers of horizontal cells ([@R40]).

We have previously identified the zinc-finger transcription factor Sall3 as prominently and selectively expressed in developing mouse retina ([@R4]). Sall3 is a homolog of the *spalt* gene of *Drosophila*, which plays a crucial role in multiple aspects of photoreceptor development ([@R12]; [@R32]; [@R47]). To determine whether Sall3 might play an evolutionarily conserved role in mammalian retinal differentiation, we conducted both gain- and loss-of-function analyses of Sall3 in developing mouse retina.

MATERIALS AND METHODS {#S2}
=====================

Animals {#S3}
-------

Timed pregnant CD-1 mice and adult C57BL/6 mice were purchased from Charles River Laboratories (Wilmington, MA, USA). *CB6-Tg(Gad1-EGFP)G42Zjh/J* mice ([@R23]) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). *Sall3* knockout mice (*Sall3^−/−^*) ([@R37]) were kindly provided by A. P. Monaghan (University of Pittsburgh, Pittsburgh, PA, USA) and *Nrl* knockout mice were kindly provided by A. Swaroop (National Institutes of Health, Bethesda, MD, USA). *Sall3^−/−^; Gad1-EGFP* mice were generated by breeding *Sall3^+/−^* mice into the *Gad1-EGFP* line and subsequent backcrossing. *Six3-Cre* mice were kindly provided by Yasuhide Furuta (M. D. Anderson Cancer Center, University of Texas, Houston, TX, USA) and *Lhx1*^lox/lox^ mice were kindly provided by Richard Behringer (M. D. Anderson Cancer Center). All experimental animal procedures were pre-approved by the Institutional Animal Care and Use Committee of the Johns Hopkins University School of Medicine.

Immunohistochemistry and TUNEL staining {#S4}
---------------------------------------

For immunohistochemical analysis of retinal cryosections, eyes were carefully dissected and intact retinas removed. The retinas were fixed in cold 4% paraformaldehyde (PFA) for 40 minutes (E16), 50 minutes \[postnatal day (P) 0\] or 1 hour (P7, P14) and then immersed in 30% sucrose in PBS overnight before embedding in O.C.T. compound (Sakura Finetek, USA). Sections (25 μm) of embedded retinas were cut on a Leica CM3050S cryostat and blocked with PBS containing 5% horse serum, 0.2% Triton X-100, 0.02% sodium azide and 0.1% BSA for 1 hour at room temperature and then subjected to immunohistochemistry as previously described ([@R11]).

Primary antibodies used were goat anti-Brn3 (1:200; C-13, sc-6026, Santa Cruz Biotechnology), mouse anti-calbindin (1:200; C9848, Sigma-Aldrich), rabbit anti-calretinin (1:200; AB5054, Chemicon), goat anti-Chat (1:100; AB144P, Chemicon), sheep anti-Chx10 (1:200; X1180P, Exalpha Biologicals), mouse anti-cone arrestin \[1:500; a generous gift of Cheryl Craft ([@R50])\], rabbit anti-Dab1 (1:200; a generous gift of Brian Howell, SUNY Upstate Medical University, Syracuse, NY, USA), mouse anti-Gad1/2 \[1:200; GAD-6, Developmental Studies Hybridoma Bank (DSHB), University of Iowa\], goat anti-GFP (1:500; 600-101-215, Rockland Immunochemicals), rabbit anti-GFP (1:1000; A6455, Invitrogen), mouse anti-glutamine synthase (GS) (1:200; 610518, BD Biosciences), rabbit anti-Glyt1 (1:200; AB1770, Chemicon), mouse anti-Ki67 (1:200; 550609, BD Pharmingen), mouse anti-Lhx1 (1:200; 4F2, DSHB), rabbit anti-Lhx2 (1:1500; generated for this study by Covance), mouse anti-NF165 (1:200; 2H3, DSHB), chicken anti-M-opsin (1:500; a generous gift of Jeremy Nathans, Johns Hopkins University School of Medicine, Baltimore, MD, USA), mouse anti-P27kip1 (1:200; 18-2370, Invitrogen), mouse anti-Pax6 (1:200; DSHB), rabbit anti-parvalbumin (1:200; PV-28, Swant), mouse anti-PKCα (1:200; 05-154, Millipore), mouse anti-Prox1 (1:200; MAB5654, Millipore), mouse anti-rhodopsin (1:200; a generous gift of Robert Molday, University of British Columbia, Vancouver, Canada), rabbit anti-Rxrγ (1:200; SC-555, Santa Cruz Biotechnology), rabbit anti-Sall3 (1:500; HPA016656, Sigma), goat anti-S-opsin (1:500; N-20, sc-14363, Santa Cruz Biotechnology) and mouse anti-syntaxin (1:200; S0664, Sigma). Secondary antibodies (1:500) used were: Alexa 568 goat anti-chicken IgG (A11041, Invitrogen); FITC-conjugated donkey anti-goat IgG (705-095-147), anti-mouse IgG (715-095-150), anti-rabbit IgG (711-095-152) and anti-sheep IgG (713-095-147) and Texas Red-conjugated donkey anti-goat IgG (705-075-147), anti-mouse IgG (715-075-150) and anti-rabbit IgG (711-075-152) (all Jackson ImmunoResearch). All section immunohistochemical data shown were imaged and photographed on a Zeiss 510 confocal microscope.

TUNEL assays were performed using a TMRred In Situ Cell Death Detection Kit as per the manufacturer\'s instructions (Roche Applied Science). E16.5 and P0 retina sections were prepared and sectioned as described above. TUNEL assays were imaged and photographed on a Zeiss 510 confocal microscope.

Retinal explant culture preparation and flatmount immunohistochemistry {#S5}
----------------------------------------------------------------------

Retinas used for explant cultures were dissected at P0 as described above in sterile PBS. The dorsal pole was marked by notching the retinal tissue. Four cuts were made using microdissection scissors and the retinas were transferred to Nucleopore Track-Etch membrane filters (Whatman) and the tissue flattened out evenly. Filters were then floated on DMEM/F12 containing 10% FBS and 1× penicillin/streptomycin in 12-well plates and incubated at 37°C for 7 or 14 days. Explants were harvested and immersed in 4% PFA for 1 hour, then immersed in 30% sucrose in PBS overnight and embedded in O.C.T. compound. Immunohistochemistry was performed as described above.

Flatmount staining was performed by removing the sclera, choroid and cornea in PBS. Retinas are then fixed in 4% PFA for 30 minutes, washed three times in PBS and blocked for 1 hour. Retinas were then incubated in primary antibody for 48 hours at 4°C with gentle agitation, washed three times in PBS for 20 minutes each and incubated in secondary antibody for 24 hours. Retinas were then washed three times for 20 minutes each in PBS, dissected, flattened and mounted with Vectashield (Vector Labs).

In vivo electroporation {#S6}
-----------------------

In vivo electroporation experiments were performed as previously described ([@R29]). pCAG-Sall3 was constructed by cloning the full-length open reading frame of the human *SALL3* gene (derived from BC148296) into the pCAGIG vector. Approximately 0.3 μl of 5 μg/μl DNA solution was injected into the subretinal space of P0 mouse retinas and square electric pulses were applied (100 volts, five 50-millisecond pulses at 950-millisecond intervals). Electroporated retinas were harvested at P14.

Microarray analysis {#S7}
-------------------

*Sall3*^+/+^ and *Sall3^−/−^* retinas were explanted as described for 7 days. Retinas were harvested and total RNA was extracted using the RNeasy Mini Kit (Qiagen). Two explants for each genotype were pooled and three replicates were prepared. The independent RNA preparations were labeled and hybridized essentially as previously described using the Affymetrix Mouse Exon 1.0 array platform ([@R36]). Data were analyzed using Spotfire (TIBCO). A list of previously identified cone-enriched genes was compiled from previously published microarray data ([@R10]; [@R24]). The *P*-value for the cone enrichment of transcripts that were significantly downregulated (*P*\<0.05) in the microarray data set relative to all detectable transcripts was calculated using one-way ANOVA. The sources for the horizontal cell-enriched genes shown in [Table 1](#T1){ref-type="table"} are as follows: *Nefm* and *Nefh* ([@R8]), *Esrrb* ([@R36]), *Tmod1* ([@R49]). Microarray data have been deposited in GEO under accession number GSE24083.

Chromatin immunoprecipitation (ChIP) {#S8}
------------------------------------

ChIP was performed using six pooled retinas from P7 C57BL/6J mice as previously described ([@R38]). A rabbit antibody to Sall3 (3 μl of 1 mg/ml; ab41740, Abcam) and the normal rabbit IgG control (Santa Cruz Biotechnology) were used for immunoprecipitation (IP). The immunoprecipitated DNA and the input (without IP) and mock (no chromatin DNA) controls were analyzed by PCR using primers spanning the promoter or 3′ regions of each gene ([@R38]). Quantitative real-time PCR was performed using the SYBR Green Jumpstart Taq Readymix qPCR Kit (Sigma) and CFX96 Real-Time PCR System (BioRad) according to the manufacturers\' protocols. The results of ChIP assays were analyzed by candidate gene-based PCR using primers spanning the promoter region of each gene. The data shown in [Fig. 6](#F6){ref-type="fig"} are representative of a minimum of three replicate experiments. Controls were performed using normal rabbit IgG (Santa Cruz Biotechnology) in IP reactions as negative controls and input without IP as positive controls for PCR reactions.

RESULTS {#S9}
=======

Sall3 is prominently expressed in differentiating horizontal interneurons and cone photoreceptors {#S10}
-------------------------------------------------------------------------------------------------

Our previous in situ hybridization data suggested that *Sall3* RNA is expressed in developing horizontal cells beginning at \~E16, with expression later detected in a subset of photoreceptors, and in an uncharacterized cell population in the retinal inner nuclear layer (INL) ([@R4]). To map Sall3 protein distribution during retinal development, we performed immunohistochemistry with antibodies to Sall3. Sall3 protein expression was first detected at E16.5 in developing horizontal cells, as determined by coexpression with the horizontal cell marker Prox1 ([Fig. 1C-J](#F1){ref-type="fig"}). Prox1 protein expression is first detected in the retina at E14.5 ([@R13]). Immunostaining for Sall3 at E14.5 demonstrated that Prox1 expression precedes that of Sall3 (see Fig. S1A-D in the supplementary material). Sall3 expression was confined to postmitotic cells, as no Sall3^+^ Ki67^+^ cells were detected at any time point analyzed (see Fig. S1E-M in the supplementary material). By P5, Sall3 protein was detected in a population of cells in both the medial INL and the outer nuclear layer (ONL) (see Fig. S1K,L and Fig. S2A,B in the supplementary material). This pattern of ONL, medial INL and horizontal cell staining persisted into adulthood (7 weeks postnatal) ([Fig. 1N](#F1){ref-type="fig"}). Immunostaining for the horizontal cell-specific markers Lhx1 ([@R27]), NF165 (Nefm) ([@R11]) and calbindin ([@R19]) confirmed that Sall3 is expressed in differentiating horizontal cells ([Fig. 2D](#F2){ref-type="fig"}; see Fig. S2A-C,G-I in the supplementary material). Sall3-expressing cells in the medial INL coexpressed the pan-bipolar marker Chx10 (Vsx2) from P7 onward ([Fig. 2E-G](#F2){ref-type="fig"}), but not the rod bipolar marker PKCα (Prkcα) ([Fig. 2H](#F2){ref-type="fig"}). Sall3-positive cells did not coexpress the Müller glia markers glutamine synthase or p27kip1 (Cdkn1b) ([Fig. 2I-L](#F2){ref-type="fig"}), further suggesting that these cells are a cone bipolar subpopulation. Sall3 protein was absent at all times from amacrine cells and retinal ganglion cells ([Fig. 1](#F1){ref-type="fig"}; data not shown).

Sall3 and short wavelength-sensitive cone opsin (Sop) were coexpressed from P7 onward in the ONL, indicating that Sall3 is expressed in retinal cones ([Fig. 3A-F,J-M](#F3){ref-type="fig"}). Notably, by P21, Sall3 immunostaining was more prominent in cones of the medial and ventral retina, where the great majority of cones express Sop, as compared with the dorsal retina ([@R21]; [@R48]). Furthermore, expression of Sall3 was only detected in a subset of medium wavelength-sensitive cone opsin (Mop)-expressing cells ([Fig. 3G-I,N-Q](#F3){ref-type="fig"}). Coexpression of Sall3 and Mop was most prominent in dorsomedial and ventromedial retina, where the overwhelming majority of cones coexpress both Mop and Sop ([@R35]; [@R48]). We thus conclude that Sall3 is selectively expressed in short wavelength-sensitive cone photoreceptors (S-cones). This finding accords with the analysis of retinas of mice mutant for *Nrl* and *Ror*β, in which rod photoreceptors are converted to an S-cone fate, and which both show a substantial increase in *Sall3* mRNA ([@R22]; [@R24]).

![**Expression of Sall3 protein during mouse retinal development.** (**A-C**) Expression of Sall3 was first identified at E16.5 in a population of cells scattered in the neuroblastic layer (NBL). (**D-F**) Expression of Sall3 remains restricted to cells in the medial NBL until P4. The boxed areas in C-F are magnified 2× in G-J. (**G-J**) These cells robustly coexpress the transcription factor Prox1, indicating that they are horizontal cells. Prox1-positive Sall3-negative cells (G, arrows) are present at E16.5 but not at E18.5-P4 (H-J). (**K-N**) Sall3 expression is upregulated in cells in the outer nuclear layer (ONL) and the medial inner nuclear layer (INL) at P7, and remains expressed in horizontal cells in the outer INL. This pattern is preserved throughout the remainder of retinal development. (**O-Q**) Antibodies to Sall3 do not stain cell bodies in the retinas of 7 day *Sall3^−/−^* retinal explants, demonstrating the specificity of the antibody. The weak staining observed in the inner plexiform layer (IPL) is a secondary antibody artifact (data not shown). GCL, ganglion cell layer. Scale bars: 100 μm in A,B; 50 μm in C-F,K-O.](DEV061846F1){#F1}

![**Coexpression of Sall3 with markers of inner retinal cell types.** (**A-C**) Sall3 is coexpressed in a subset of Prox1-expressing cells (arrows) in the outer INL adjacent to the outer plexiform layer (OPL) at P7, P14 and P21. Furthermore, Sall3-expressing cells in the medial INL do not coexpress Prox1. (**D**) Sall3 is coexpressed (arrows) with the horizontal cell marker calbindin (Calb) in cells in the outer INL at P21. (**E-G**) Sall3-positive cells (arrowheads) in the medial but not outer INL (yellow arrows) coexpress Chx10 after the first postnatal week, indicating that they are bipolar cells. (**H**) Sall3-positive bipolar cells do not coexpress PKCα, implying that they are not rod bipolar cells. (**I-L**) Sall3-positive cells do not express the Müller glia markers glutamine synthase (GS) (I,J) and P27kip1 (K,L). Scale bars: 50 μm.](DEV061846F2){#F2}

Sall3 is necessary and sufficient for expression of S-cone-specific genes {#S11}
-------------------------------------------------------------------------

To determine whether Sall3 might be sufficient to drive other retinal cell types toward a cone fate, we used in vivo electroporation of plasmids expressing full-length Sall3 under the control of the ubiquitous *CAG* promoter to overexpress Sall3 beginning at P0.5 ([@R29]; [@R34]). Electroporation of CAG-Sall3 induced both Sop and cone arrestin (Arr3) ([@R50]) expression in a large fraction of electroporated cells ([Fig. 4A-L](#F4){ref-type="fig"}). Thirty-five percent of all pCAG-Sall3-electroporated cells coexpressed Sop, compared with 0.164% of cells electroporated with pCAGIG control construct (*P*\<0.0005; *n*=5) ([Fig. 4S](#F4){ref-type="fig"}). Furthermore, 9.5% of cells electroporated with pCAG-Sall3 expressed Arr3, whereas only 0.898% of GFP-positive controls were Arr3 positive (*P*\<0.0005; *n*=5) ([Fig. 4T](#F4){ref-type="fig"}). In sharp contrast, no induction of Mop was observed following Sall3 overexpression (*P*\>0.05; *n*=5) ([Fig. 4M-R,U](#F4){ref-type="fig"}), nor was rhodopsin expression repressed in electroporated cells (see Fig. S3 in the supplementary material). Electroporated photoreceptors showed no change in outer segment length or in the position of their cell bodies, nor did they show cone-like morphology. We also observed that overexpression of Sall3 induced Sop expression in a subset of electroporated cells that resembled wide-field amacrine cells, indicating that Sall3 is sufficient to induce cone opsin expression in non-photoreceptor cells ([Fig. 4F](#F4){ref-type="fig"}, arrows).

In light of the prominent expression of Sall3 in developing cones, we examined the expression of cone-specific markers in retinas of *Sall3*^−/−^ mice. We observed no difference in the expression of the early cone marker Rxrγ in P0 retinas of wild-type and knockout animals, implying that cone specification occurs normally in *Sall3*^−/−^ retinas (see Fig. S4 in the supplementary material). Owing to the neonatal lethality of the *Sall3* knockout, retinal explant cultures were examined to investigate whether cone development proceeds normally. In P0 retinas that were explanted in vitro for 7 days (P0-7DIV), we observed a virtual elimination of the expression of a number of cone-specific genes, including both *Arr3* ([Fig. 5A,B](#F5){ref-type="fig"}) and *Sop* ([Fig. 5C,D](#F5){ref-type="fig"}). Arr3 expression was absent in P0-7DIV *Sall3*^−/−^ retinal explants ([Fig. 5B](#F5){ref-type="fig"}), but a few Sop-positive cells were detected. However, these Sop-positive cells showed abnormal morphology, including truncated outer segments and the positioning of cell soma immediately adjacent to the outer limiting membrane ([Fig. 5D](#F5){ref-type="fig"}, arrows). This drastic reduction in Sop expression was also observed in 14 day (P0-14DIV) *Sall3*^−/−^ retinal explants (see Fig. S5F in the supplementary material, arrow). In P0-14DIV *Sall3*^−/−^ explants, a few Arr3-positive cells were seen, although many fewer than in wild-type explants (see Fig. S5I,L in the supplementary material, arrow). Mop expression could not be examined because neonatal retinal explants do not express Mop protein ([@R46]). Finally, rod numbers were unaffected in *Sall3*^−/−^ P0-14DIV explants, with expression of rhodopsin expressed normally in rods (see Fig. S5M-R in the supplementary material).

To determine whether Sall3 directly regulates the expression of Sop, Mop and/or Arr3, we performed chromatin immunoprecipitation (ChIP) from P7 C57BL/6J wild-type mouse retinas. We observed that Sall3 bound directly to the promoters of these genes, but did not bind to the 3′ regions of these genes or to the promoters of genes that are selectively expressed in rods or rod bipolar cells ([Fig. 6](#F6){ref-type="fig"}). Interestingly, although our overexpression experiments did not reveal any significant changes in Mop expression, ChIP experiments suggested that Sall3 binds to the promoter of this gene in vivo. These data are in line with other Fig. 3.**Coexpression of Sall3 with Sop and Mop in cone photoreceptors of the developing retina.** (**A-F**) Sall3 is coexpressed with Sop in mouse cone photoreceptors at P7 and P14. (**G-I**) Sall3 is only coexpressed with a subset of Mop-expressing photoreceptors at P14. (**J-M**) Sall3 expression in cones correlates with levels of Sop expression along the dorsoventral retinal axis at P21. Sections are taken at the following positions along an axis running through the central retina, where 0% is most dorsal and 100% most ventral: dorsal (10%), dorsomedial (35%), ventromedial (60%) and ventral (85%). (**N-Q**) Limited Sall3 expression is observed in the dorsal retina, where most cones predominantly express Mop. Sall3 is coexpressed with Mop in the dorsomedial and ventromedial retina, where the majority of cells coexpress Sop and Mop. Strong expression of Sall3 is seen in ventral retina, where only Sop-positive and Sop^+^ Mop^+^ cones are observed. Scale bars: 50 μm. studies that have reported a considerable degree of redundancy and crosstalk among transcription factors involved in the regulation of photoreceptor-specific gene expression ([@R34]; [@R39]; [@R38]).

In vivo electroporation of Sall3 results in the generation of ectopic horizontal cells in the inner retina {#S12}
----------------------------------------------------------------------------------------------------------

Since Sall3 is also expressed in retinal horizontal cells, we next examined the expression of horizontal cell markers in cells overexpressing Sall3 at P14. Overexpression of Sall3 altered the morphology of electroporated cells in the INL, which displayed a wide-field lateral dendritic morphology reminiscent of horizontal cells ([Fig. 7](#F7){ref-type="fig"}). We hypothesized that these could be horizontal cells that were ectopically positioned adjacent to the inner plexiform layer (IPL). Overexpression of Sall3 did not induce expression of either of the horizontal cell markers Lhx1 Fig. 4.**Overexpression of Sall3 by in vivo electroporation of P0 retinas results in ectopic expression of S-cone markers at P14.** (**A-F**) Expression of Sop in mouse retinas electroporated with control pCAGIG (A-C) and pCAG-Sall3 (D-F) constructs. Overexpression of Sall3 results in ectopic expression of Sop in the ONL (F) and in subsets of electroporated cells in the INL (F, arrows). (**G-L**) Expression of cone arrestin (Arr3) in retinas electroporated with control (G-I) and Sall3 (J-L) overexpression constructs. Overexpression of Sall3 results in the ectopic expression of Arr3 in the ONL of electroporated retinas (L). (**M-R**) Expression of Mop in retinas electroporated with control (M-O) and Sall3 (P-R) expression constructs. (**S-U**) Quantification of Sop (S), Arr3 (T) and Mop (U) expression in electroporated retinas at P14. Sop: 0.0016±0.003 control versus 0.35±0.067 Sall3; *n*=5, \**P*=0.0003. Arr3: 0.009±0.016 control versus 0.09436±0.0234 Sall3; *n*=5, \**P*=0.0003. Mop: 0.0005±0.0011 control versus 0.006±0.0014 Sall3; *n*=5, *P*=0.8677. Error bars indicate s.d. Scale bars: 50 μm. and calbindin ([Fig. 7A-F,S-X](#F7){ref-type="fig"}), but a robust induction of Prox1 was observed in electroporated horizontal-like cells localized adjacent to the IPL ([Fig. 7L](#F7){ref-type="fig"}, arrows). Since Prox1 is expressed in AII amacrine cells in the mouse retina ([@R13]), we investigated whether Prox1-expressing cells generated following Sall3 overexpression were abnormal AII amacrine cells, but did not detect expression of the AII amacrine markers Dab1, calretinin (Calb2), parvalbumin and Glyt1 (Slc6a9) (see Fig. S6 in the supplementary material). Furthermore, overexpression of Sall3 resulted in the expression of NF165 in the lateral dendrites of these same horizontal-like cells ([Fig. 7R](#F7){ref-type="fig"}, arrow), which was never observed in cells electroporated with the pCAGIG control plasmid ([Fig. 7M-O](#F7){ref-type="fig"}). These data imply that Sall3 overexpression can induce both the expression of a subset of horizontal cell markers and a horizontal cell-like morphology in late-born retinal cells, but cannot completely respecify these cells to a horizontal fate.

![***Sall3*^+/+^*; Gad1-EGFP* and *Sall3*^−/−^; *Gad1-EGFP* P0 retinas explanted for 7 days in vitro (P0-7DIV) demonstrate defects in cone photoreceptor development.** (**A**,**B**) Arr3 expression in *Sall3^+/+^* and *Sall3^−/−^* mouse retinal explants. Arr3 is expressed in the ONL in *Sall3^+/+^* explants (A, arrows). *Sall3^−/−^* explants lack Arr3 expression (B). (**C**,**D**) Sop expression in *Sall3^−/−^* and *Sall3^+/+^* retinal explants. Sop is robustly expressed in the ONL of *Sall3^+/+^* explants (C), whereas *Sall3^−/−^* explants display severely reduced numbers of Sop-positive cells in the ONL (D, arrows). The *Gad1-EGFP* transgene was used to visualize horizontal cell morphology. Scale bars: 50 μm.](DEV061846F5){#F5}

Loss of function of Sall3 disrupts horizontal cell differentiation {#S13}
------------------------------------------------------------------

To examine the effects of Sall3 loss of function (LOF), we conducted immunohistochemical analysis of wild-type and *Sall3*^−/−^ retinas using molecular markers of horizontal cells. At P0.5, both section and flatmount immunohistochemistry showed a dramatic reduction of NF165-positive horizontal cells ([Fig. 8](#F8){ref-type="fig"}). This effect was especially pronounced in ventral retinas of *Sall3*^−/−^ mice as compared with wild-type controls, with a less prominent reduction in the dorsal retina ([Fig. 8A,K,N](#F8){ref-type="fig"}). A statistically significant 38% reduction in cell number was observed in dorsal retina (*P*\<0.002), with cell number in the ventral retina reduced by two-thirds (*P*\<0.0002) ([Fig. 8O](#F8){ref-type="fig"}).

To better visualize the morphology and position of horizontal cells, the *Gad1-EGFP* transgene was bred into the *Sall3*^−/−^ line, as GFP fluorescence readily allows robust visualization of horizontal cell morphology ([@R23]). The number of GFP-positive cells was reduced in the medial neuroblastic layer (NBL) in *Sall3*^−/−^ mice ([Fig. 8C-N](#F8){ref-type="fig"}). However, compared with wild-type samples, cells within the medial NBL of *Sall3^−/−^* retinas that coexpressed NF165 and GFP did not demonstrate any clear difference in the relative intensity of either NF165 or GFP staining.

To determine whether Sall3 LOF results in increased apoptosis, we performed TUNEL assays on *Sall3^−/−^* and *Sall3*^+/+^ retinas at E16.5 and P0 (see Fig. S7 in the supplementary material). No difference in TUNEL labeling was observed in the *Sall3^−/−^* animals as compared with controls at either time point.

![**ChIP assay demonstrating direct binding of Sall3 to promoters of cone-specific genes.** (**A**) Sall3 binds to the promoter of the cone-specific genes *Arr3, Sop* and *Mop*, but not to the promoter of the rod-specific gene rhodopsin (*Rho*) or the bipolar-specific gene *Grm6*. Sall3 does not bind to the 3′ regions of cone-, rod- or bipolar-specific genes. Sall3-IP, Sall3 immunoprecipitation; IgG-IP, non-specific rabbit IgG control; mock, no chromatin negative control; input, PCR positive control. (**B**) Quantitative real-time PCR experiment representing IP to input ratio (%) following normalization to the IgG control values. *Arr3*, 4.69%; *Mop*, 5.57%; *Sop*, 5.89%; *Rho*, 0.1%. Error bars represent s.e.m. from three independent experiments (*n*=3).](DEV061846F6){#F6}

Loss of function of Sall3 results in downregulation of Lhx1 in horizontal cells {#S14}
-------------------------------------------------------------------------------

To investigate how Sall3 LOF disrupts horizontal cell development, we examined the expression of transcription factors that regulate horizontal cell development. At E16.5, expression of Prox1 and Lhx1 did not substantially differ between wild-type and *Sall3*^−/−^ retinas (see Fig. S8 in the supplementary material). At P0, however, Lhx1 expression was almost completely absent from horizontal cells of *Sall3*^−/−^ mice ([Fig. 9A-F,S](#F9){ref-type="fig"}). Prox1 expression was not as severely affected as Lhx1 in *Sall3*^−/−^ mice. There was a reduction in Prox1-positive cells in the dorsal retina, but this was very mild relative to that seen for Lhx1 ([Fig. 9T](#F9){ref-type="fig"}). Expression of the retinal ganglion cell marker Brn3 (Pou4f1), the retinal progenitor, ganglion, amacrine and horizontal cell marker Pax6, and the progenitor markers Chx10 and Lhx2 was unaffected ([Fig. 9A-L](#F9){ref-type="fig"}). This implies that Sall3 is required to maintain expression of Lhx1 in horizontal cells while they undergo radial migration, but is not necessary to initiate the expression of Lhx1 during outward radial migration. Using a *Six3-Cre; Lhx1*^lox/lox^ line, we were able to selectively inactivate Lhx1 expression in retina. As previously described, Lhx1 immunoreactivity was eliminated in these mice ([@R40]). Expression of Sall3 in photoreceptors and putative cone bipolar cells was unaffected in these animals (see Fig. S2J-R in the supplementary material). Lhx1 LOF resulted in a substantial reduction in the number of horizontal cells in the outer INL (see Fig. S2J,M,P in the supplementary material). However, the remaining horizontal cells expressed Sall3, Prox1 and NF165 Fig. 7.**Overexpression of Sall3 by in vivo electroporation of P0 retinas results in expression of horizontal cell markers in the INL at P14.** (**A-F**) Expression of Lhx1 in mouse retinas electroporated with control pCAGIG (A-C) and pCAG-Sall3 (D-F) plasmids. (**G-L**) Expression of Prox1 in retinas electroporated with control (G-I) and pCAG-Sall3 (J-L) constructs. Cells in the inner INL coexpress Prox1 in retinas electroporated with pCAG-Sall3 (L, arrows) but not with pCAGIG (I). (**M-R**) Expression of NF165 in retinas electroporated with pCAGIG (M-O) and pCAG-Sall3 (P-R). Cells in the inner INL electroporated with pCAG-Sall3 express NF165 (R, arrow) but not following electroporation with pCAGIG (O). (**S-X**) Expression of calbindin in retinas electroporated with control (S-U) or pCAG-Sall3 (V-X) plasmids. Scale bars: 50 μm. (see Fig. S2M,P in the supplementary material, arrows). Furthermore, ectopic horizontal cells could be identified in close proximity to the IPL, as determined by coexpression of Sall3 and Prox1 (see Fig. S2M in the supplementary material, arrowhead). These data suggest that, whereas Sall3 is required to maintain expression of Lhx1 postnatally, Lhx1 is not required for the expression of Sall3 in horizontal cells.

We next examined retinal explants at later developmental stages to further investigate the effects of Sall3 LOF on horizontal cell development. In P0-7DIV retinal explants of *Sall3^+/−^; Gad1-EGFP* mice, the overwhelming majority of GFP-positive horizontal cell bodies were found in the outer portion of the INL ([Fig. 10A](#F10){ref-type="fig"}, white arrows). These cells expressed calbindin and the *Gad1-EGFP* transgene and extended GFP-positive dendrites tangentially through the outer plexiform layer (OPL). Coexpression of calbindin and GFP was specific to horizontal cells, with separate subpopulations of amacrine cells expressing calbindin or GFP ([Fig. 10A](#F10){ref-type="fig"}, asterisks). A limited number of radially migrating calbindin^+^ GFP^+^ horizontal cell precursors were also observed in the ONL at this stage ([Fig. 10A](#F10){ref-type="fig"}, orange arrow). In *Sall3*^−/−^*; Gad1-EGFP* mice, calbindin^+^ GFP^+^ horizontal cells were not detected. Robust calbindin expression was not observed in the OPL ([Fig. 10B](#F10){ref-type="fig"}), although rare calbindin-positive soma were sometimes seen positioned either apical or basal to the OPL ([Fig. 10B](#F10){ref-type="fig"}, white arrow), and a much reduced number of GFP-positive horizontal cell bodies was observed in the outer portion of the INL ([Fig. 10B](#F10){ref-type="fig"}, yellow arrow).

To further investigate the fate of horizontal cells that would normally be present adjacent to the OPL, we analyzed NF165 immunofluorescence in both genetic backgrounds. The dendrites of horizontal cells in *Sall3*^+/+^*; Gad1-EGFP* mice were robustly positive for both NF165 and GFP, with intense colabeling observed throughout the OPL ([Fig. 10C](#F10){ref-type="fig"}, arrows). Furthermore, little NF165 expression and no coexpression of NF165 and GFP was observed in the IPL of *Sall3*^+/+^*; Gad1-EGFP* retinas. In sharp contrast, *Sall3*^−/−^*; Gad1-EGFP* mice showed very weak expression of NF165 in the OPL ([Fig. 10D](#F10){ref-type="fig"}); the few correctly positioned GFP-positive cell bodies extended grossly atrophic NF165-positive dendritic processes ([Fig. 10D](#F10){ref-type="fig"}, asterisks). Significant populations of GFP-positive cells were observed in *Sall3*^−/−^*; Gad1-EGFP* retinas, with soma located in the inner INL and extending lateral NF165-positive dendrites along the scleral border of the IPL ([Fig. 10D](#F10){ref-type="fig"}, arrows). All horizontal cells in wild-type retinas were robustly positive for both GFP and Prox1 ([Fig. 10E](#F10){ref-type="fig"}, arrows), and Prox1^+^ GFP^+^ cells were not detectable in other regions of the INL or the ganglion cell layer (GCL). In *Sall3*^−/−^*; Gad1-EGFP* mice, however, in addition to the rare correctly positioned horizontal cell bodies that coexpressed Prox1 and GFP ([Fig. 10F](#F10){ref-type="fig"}, white arrow), a number Fig. 8.***Sall3*^−/−^ mice show fewer horizontal interneurons in the ventral retina.** (**A**,**B**) P0 flatmounts show fewer NF165-positive horizontal cells in *Sall3^−/−^* than *Sall3^+/+^* retinas. Decreased NF165 expression is most prominent in the ventral portion of *Sall3^−/−^* retinas (A). (**C-N**) Localization of NF165 and GFP in dorsal and ventral P0 sections of *Sall3*^+/+^*; Gad1-EGFP* and *Sall3^−/−^; Gad1-EGFP* retinas. (C-E) *Sall3^+/+^* dorsal retinas feature elaborate NF165^+^ GFP^+^ horizontal cells in the medial NBL. (F-H) Ventral *Sall3^+/+^* retinas display NF165-positive horizontal cells; however, fewer horizontal cells coexpress GFP. (I-K) Expression of NF165 and Gad1-EGFP in dorsal *Sall3^−/−^; Gad1-EGFP* retinas reveals a decreased number of NF165^+^ GFP^+^ cells. (L-N) Expression of NF165 and GFP in ventral *Sall3^−/−^; Gad1-EGFP* retinas demonstrates substantially diminished numbers of NF165^+^ GFP^+^ cells. (**O**) Quantification of NF165-positive horizontal cells in P0 dorsal and ventral *Sall3^+/+^* and *Sall3^−/−^* retinas: Dorsal retina: 49.33±13.03 *Sall3*^−/−^ versus 81.32±4.32 *Sall3^+/+^*; *n*=5, \**P*=0.0011. Ventral retina: 23±11.33 *Sall3*^−/−^ versus 60.17±8.66 *Sall3^+/+^*; *n*=5, \**P*=0.0001. Error bars indicate s.d. Scale bars: 2 mm in A,B; 50 μm in E,H,K,N. of cells in both the inner INL and GCL were now also seen to coexpress both markers ([Fig. 10F](#F10){ref-type="fig"}, yellow arrows); such cells were not detected in *Sall3*^+/+^*; Gad1-EGFP* mice.

In P0-14DIV retinal explants, we likewise observed reduced NF165 expression in the OPL (see Fig. S9M-R in the supplementary material), but noted robust expression of NF165 in the IPL. Expression of calbindin remained virtually absent in the Fig. 9.**Expression of the horizontal cell markers Lhx1, Prox1 and Pax6, the retinal ganglion cell marker Brn3 and the retinal progenitor markers Lhx2 and Chx10 in P0 *Sall3*^−/−^ and *Sall3^+/+^* retinas.** (**A-F**) Lhx1 and Brn3 immunostaining of *Sall3^+/+^* and *Sall3^−/−^* mouse retinas at P0. Lhx1-expressing horizontal cells were present in *Sall3^+/+^* (C, arrowheads) but not *Sall3^−/−^* (F) retinas. (**G-L**) Prox1 and Lhx2 immunostaining of *Sall3^−/−^* and *Sall3^+/+^* retinas at P0. Prox1-expressing horizontal cells are present in *Sall3^+/+^* (I, arrowheads) and *Sall3^−/−^* (L, arrowheads) retinas. (**M-R**) Chx10 and Pax6 immunostaining of *Sall3^+/+^* and *Sall3^−/−^* retinas at P0. Pax6-expressing horizontal cells are present in *Sall3^+/+^* (O, arrowheads) and *Sall3*^−/−^ (R, arrowheads) retinas. (**S**) Quantification of Lhx1-positive horizontal cells in P0 dorsal and ventral *Sall3^−/−^* and *Sall3^+/+^* retinas. Dorsal retina: 116.4±8.5 *Sall3^+/+^* versus 7.3±9.9 *Sall3^−/−^*; *n*=3, \**P*=0.00015. Ventral retina: 96.3±13.3 *Sall3^+/+^* versus 6.0±7.4 *Sall3*^−/−^; *n*=3, \**P*=0.0016. (**T**) Quantification of Prox1-positive horizontal cells in P0 dorsal and ventral *Sall3^+/+^* and *Sall3^−/−^* retinas. Dorsal retina: 115.7±12.0 *Sall3^+/+^* versus 80.3±8.1 *Sall3*^−/−^; *n*=3, \**P*=0.017. Ventral retina: 90.7±6.2 *Sall3^+/+^* versus 79.7±12.5 *Sall3*^−/−^; *n*=3, *P*=0.27. Error bars indicate s.d. Scale bars: 50 μm. OPL, and appropriately positioned calbindin-positive horizontal cell soma were rarely seen (see Fig. S9S-X in the supplementary material). These data imply that Sall3 LOF results in the mislocalization of a subset of differentiating horizontal cells to the inner portion of the INL, similar to what is observed in *Chx10-Cre; Lhx1*^lox/lox^ retinas ([@R40]). Sall3 LOF does not affect the initiation of Lhx1 expression in horizontal cells, and these cells Fig. 10.**Horizontal cell development is disrupted in P0-7DIV *Sall3*^−/−^ retinas.** (**A**,**B**) Calbindin and GFP expression. Calbindin^+^ GFP^+^ horizontal cells are localized in the outer INL (A, white arrows) in wild-type retinas, whereas GFP-positive cells in the inner INL are calbindin-negative (A, asterisks). Occasionally, calbindin^+^ GFP^+^ migrating horizontal cells are seen in the ONL (A, orange arrow). *Sall3^−/−^* retinas lack calbindin^+^ GFP^+^ horizontal cells; however, cells positive for either calbindin (B, white arrow) or GFP (B, yellow arrow) are still seen in the outer INL. (**C**,**D**) NF165 and Gad1-EGFP expression. NF165^+^ GFP^+^ horizontal cell processes are found in the OPL (C, yellow arrows) in *Sall3*^+/+^*; Gad1-EGFP* retinas. *Sall3^−/−^; Gad1-EGFP* retinas display few NF165^+^ GFP^+^ horizontal cell processes in the OPL (D, asterisks) and NF165^+^ GFP^+^ processes are localized in the IPL (D, yellow arrows). (**E**,**F**) Prox1 and GFP expression. Prox1^+^ GFP^+^ cells are localized adjacent to the OPL in *Sall3*^+/+^*; Gad1-EGFP* retinas (E, arrows). A reduced number of Prox1^+^ GFP^+^ cells is found adjacent to the OPL in *Sall3^−/−^* mice (F, white arrow), and Prox1^+^ GFP^+^ cells are now localized adjacent to the IPL (F, yellow arrows). Prox1-positive cells can also be found in the GCL of *Sall3^−/−^* retinas (F, asterisks). Scale bars: 50 μm. appear to undergo outward radial migration normally, unlike *Lhx1^−/−^* horizontal cells, which generally do not undergo outward radial migration. However, most Sall3-deficient horizontal cells do not take up residence adjacent to the developing OPL but instead localize to the vitreal face of the INL, extending their dendrites laterally in the IPL.

Sall3 loss of function globally disrupts the expression of horizontal cell- and S-cone-specific genes {#S15}
-----------------------------------------------------------------------------------------------------

To determine whether additional developmental defects result from Sall3 LOF, we performed triplicate microarray analysis of P7 retinal explants obtained from wild-type and *Sall3^−/−^* mice. Through a survey of the literature, along with the previously published Table 1.Microarray analysis of gene expression in P7 retinal explants from wild-type and *Sall3^−/−^* mice microarray analysis of *Nrl^−/−^* and *Ror*β*^−/−^* mice, we were able to obtain a list of over 110 cone-enriched transcripts ([@R4]; [@R22]; [@R24]) (see Table S1 in the supplementary material). We observed that cone-enriched transcripts were significantly downregulated in *Sall3^−/−^* retinas (*P*\<2.0×10^−4^). Notably, we found that cone-specific components of the phototransduction pathway were particularly downregulated, with *Sop* (*Opn1sw*) being the second most highly downregulated transcript identified ([Table 1](#T1){ref-type="table"} and see Fig. S10 in the supplementary material), although some cone-specific genes such as *Cnga3* showed only modest changes in mutant retinas, and the expression of other cone-specific phototransduction components, such as *Gnat2* and *Gnb3*, was unaffected ([Table 1](#T1){ref-type="table"}). In comparison, among horizontal cell-enriched genes, only *Lhx1* showed a greater than 2-fold downregulation in expression that was statistically significant (*P*\<0.0003). The horizontal cell-enriched intermediate filament proteins, such as *NF165* and *Tmod1*, showed a less than 2-fold downregulation in expression ([Table 1](#T1){ref-type="table"}), whereas other horizontal cell-enriched genes, such as *Nefh, Borg4* (*Cdc42ep4*), septin 4, *Prox1* and calbindin showed little change in expression ([@R4]). Transcripts that were upregulated in *Sall3^−/−^* mice did not show any significant enrichment for known retinal cell type-specific transcripts. Finally, despite the prominent expression of Sall3 in a subset of bipolar cells, known bipolar cell genes showed no significant changes in expression in the *Sall3^−/−^* retina ([@R25]) (see Table S1 in the supplementary material).

DISCUSSION {#S16}
==========

Our findings demonstrate that Sall3 plays a crucial role in regulating the development of both cone photoreceptors and horizontal interneurons. Our model of Sall3 action is summarized in [Fig. 11](#F11){ref-type="fig"}. Sall3 is necessary for the expression of a range of cone-specific genes, with only a very small number of Sop-positive and Arr3-positive cells detectable in *Sall3^−/−^* retinas. Microarray experiments revealed that many other cone-enriched transcripts are selectively downregulated in *Sall3^−/−^* retinas, including *Pde6c, Pde6h* and *Crb1*, whereas some, such as *Gnat2* and *Gnb3*, show little or no change. Strikingly, overexpression of Sall3 by electroporation was sufficient to induce the expression of both Sop and Arr3, not only in photoreceptors but also in a subset of cells in the INL, without affecting expression of Mop. Rod photoreceptors overexpressing Sall3 in electroporated retinas were Fig. 11.**Role of Sall3 in horizontal cell and S-cone photoreceptor development.** (**A**) Sall3 and Lhx1 expression is activated in postmitotic horizontal cell precursors, which express Ptf1a and Prox1. Expression of Sall3 maintains Lhx1 expression in differentiating horizontal cells. Loss of Sall3 expression results in horizontal cells being displaced radially to the IPL and losing expression of calbindin. Blue, M-phase retinal progenitor cell; green, newly postmitotic horizontal cell beginning inward radial migration; yellow, horizontal cell precursor beginning outward radial migration; orange, horizontal cell precursor that has completed outward radial migration; red, mature wild-type horizontal cell; maroon, displaced mature *Sall3*^−/−^ horizontal cell. (**B**) Expression of Sall3 in Rxrγ-positive cone precursors directly activates the expression of Sop and Arr3 but not the cone alpha transducin subunit (Gnat2). ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. morphologically indistinguishable from those of controls. These rod photoreceptors that overexpressed Sall3 retained their normal morphology, laminar position and pattern of expression of cell-specific markers.

These data imply that Sall3 is activated in Sop-expressing photoreceptors undergoing terminal differentiation, and that Sall3 itself might directly activate a subset of cone-specific genes in a coordinated manner, analogous to the orphan nuclear hormone receptor Errβ (Esrrb) in rod photoreceptors ([@R36]). Several different nuclear hormone receptors, along with the transcriptional co-regulator Pias3, have been shown to be required for medium wavelength-sensitive cones to activate the expression of Mop while simultaneously repressing the expression of Sop. Sall3, however, represents the first cone-expressed transcription factor that selectively actives the expression of Sop.

The strong activation of S-cone-specific transcripts by Sall3 implies a surprising functional homology with the Spalt gene complex of *Drosophila* in the regulation of photoreceptor differentiation. In *Drosophila*, Spalt genes are necessary for specification of the inner R7 and R8 photoreceptors, which are responsible for color discrimination and in many respects form a cone-like photoreceptor class in the compound eye. Strikingly, loss of function of Spalt genes results in the ectopic expression of Rh1 opsin (NinaE), which is normally expressed in the outer R1-R6 photoreceptors, in the R7 and R8 cells, whereas expression of Rh3-Rh6 is lost ([@R12]; [@R32]). However, axonal projections of inner photoreceptors are unaltered in *Drosophila sal* mutants. This partial shift in photoreceptor identity resembles that seen following Sall3 overexpression in rod photoreceptors. These cells appear morphologically normal and continue to express rhodopsin, but now robustly express cone-specific genes. Notably, Spalt genes are selectively expressed in blue-sensitive Rh5-positive R8 photoreceptors and are required for expression of Rh5 opsin ([@R47]).

In mice, we observe that Sall3 is both necessary and sufficient for the expression of blue-sensitive cone opsin but not green-sensitive cone opsin. Such a direct conservation of gene function in photoreceptor development is unusual, and even more surprising because the blue-sensitive visual opsins of insects and vertebrates evolved independently ([@R45]). Although this observation might represent evolutionary convergence, it could alternatively imply that ancestral bilateria possessed a dedicated short wavelength-sensitive photoreceptor cell type, the differentiation of which was guided by a Spalt family gene, with the blue-sensitive opsin gene expressed by this cell having changed in different lineages; photoreceptors might, at one point, have coexpressed both blue-sensitive ciliary and rhabdomeric opsins. This possibility is not without precedent, as both vertebrate and invertebrate photoreceptors are known to coexpress different opsin genes with similar spectral sensitivities ([@R30]; [@R42]). In some cases, opsin genes with similar spectral sensitivity but which are nonetheless highly divergent at the molecular level are coexpressed, such as the blue-sensitive melanopsin and retinal cone opsins of the chick retina ([@R2]; [@R3]). Analysis of Spalt family gene expression in invertebrates from multiple phyla with well-characterized color vision should further clarify this finding.

Sall3 also plays a pivotal role in regulating the differentiation of horizontal cells, one of two cell types directly postsynaptic to cone photoreceptors, and might do so in part through maintenance of Lhx1 expression. We did not observe defects in the expression of other previously reported horizontal cell-expressed transcription factors in *Sall3*^−/−^ retinas, including Pax6, Foxn4 and Ptf1a, although cell counts did reveal a reduction in the number of Prox1-positive cells in the dorsal retina at P0. However, the final laminar position of *Sall3^−/−^* horizontal cells closely resembles that seen in *Lhx1* mutants. Horizontal cells of *Chx10-Cre; Lhx1*^lox/lox^ mutants fail to undergo initial outward radial migration, resulting in ectopic localization to the inner INL and extension of their dendritic arbor within the IPL ([@R40]; [@R41]). Horizontal cells of *Sall3*^−/−^ retinas appear to initiate Lhx1 expression and undergo outward radial migration normally. However, by P0, Lhx1 expression is drastically reduced, and at later ages the majority of horizontal cell bodies are found at the scleral border of the IPL, eventually taking up residence with amacrine cells and extending dendrites into the IPL, phenocopying the *Lhx1* mutants. The phenomenon of ectopic inner nuclear/plexiform layer-associated horizontal cells was also seen in Sall3 overexpression experiments in which Sall3 appeared to be sufficient to at least partially specify horizontal cells, including activating Prox1 and NF165. The lack of coexpression with markers specific to AII amacrine cells indicated that the Prox1-expressing wide-field cells generated in Sall3 electroporation experiments were not a dysmorphic AII population. This does not exclude the possibility that Sall3 overexpression results in the generation of a rare Sall3^+^ Prox1^+^ wide-field amacrine subclass. Notably, Spalt genes also regulate *prospero* expression in developing *Drosophila* photoreceptors, which then acts to guide differentiation of the R7 photoreceptor subtype ([@R9]; [@R12]). Overexpression of Sall3 in neonatal retinas was not sufficient to induce expression of Lhx1, and, consequently, the horizontal-like cells demonstrated the same ectopic positioning seen in *Lhx1* and *Sall3* mutants.

The crucial role of Sall3 in regulating Lhx1 expression is further underlined by our microarray analysis, which indicates that *Lhx1* is one of the most strongly downregulated genes in *Sall3*^−/−^ retinas. Taken together, these data suggest that sustained Lhx1 expression might regulate multiple stages of horizontal cell migration, and that Sall3 is necessary to maintain Lhx1 expression during the postnatal differentiation of horizontal cells. A limited number of Sall3^+^ NF165^+^ and Sall3^+^ Prox1^+^ horizontal cells are present in *Six3-Cre; Lhx1*^lox/lox^ retinas, implying that Sall3 regulates aspects of horizontal cell development at least in part through an Lhx1-independent pathway and that expression of Sall3 itself might not require Lhx1.

A subset of bipolar interneurons selectively expressed Sall3. Dedicated S-cone-selective bipolar cells in the mouse retina that are analogous to primate S-cone-selective midget bipolar cells have been identified ([@R21]). The tantalizing possibility exists that Sall3 might regulate the differentiation of S-cones and their dedicated bipolar interneuron. However, the microarray analysis did not reveal any significant changes in known mouse bipolar-expressed genes, and the role of Sall3 in bipolar interneuron development remains to be resolved.
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